Published recall report · Quality failureUpdated · 5 months ago
Wells Pharma of Houston LLC recall: fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 50 mcg/5mL)(10 mcg per mL), wells pharma, NDC 73702-202-15.
fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 50 mcg/5mL)(10 mcg per mL), wells pharma, NDC 73702-202-15.
Current recall status is unverified. FDA does not update drug-enforcement status after publication. Check the latest official information or ask a pharmacist.
What to do
Check the lot number on your pack against this recall and follow the firm's instructions. Do not stop taking a prescribed medicine without talking to a pharmacist or doctor first.
FDA public enforcement report, opens in a new tabWhich products
fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 50 mcg/5mL)(10 mcg per mL), wells pharma, NDC 73702-202-15.
- Producer
- Wells Pharma of Houston LLC
020226202150202
- Dates on pack
- Lot 020226202150202, Exp Date 05/05/2026.
More detail
cGMP deviations.
In the news
Reporting from news publishers. Follow the official notice for product advice.
No news stories about this recall yet.